A1 Refereed original research article in a scientific journal

Hemodynamic implications of mitral annular calcification in patients undergoing transcatheter aortic valve implantation for severe aortic stenosis




AuthorsHirasawa Kensuke, Butcher Steele C, Pereira Ana Rita, Meucci Maria Chiara, Stassen Jan, van Rosendael Philippe, Marsan Nina Ajmone, Bax Jeroen J, Delgado Victoria

PublisherSpringer Dordrecht

Publication year2023

JournalInternational Journal of Cardiovascular Imaging

Journal name in sourceINTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING

Journal acronymINT J CARDIOVAS IMAG

Volume39

Issue11

First page 2183

Last page2192

Number of pages10

ISSN1569-5794

eISSN1875-8312

DOIhttps://doi.org/10.1007/s10554-023-02931-w

Web address https://doi.org/10.1007/s10554-023-02931-w

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/181458632


Abstract

Purposes

Predicting hemodynamic changes of stenotic mitral valve (MV) lesions with mitral annular calcification (MAC) following transcatheter aortic valve implantation (TAVI) may inform clinical decision-making. This study aimed to investigate the association between the MAC severity quantified by computed tomography (CT) and changes in mean transmitral gradient (mTMG), mitral valve area (MVA) and stroke volume index (SVi) following TAVI.

Methods and results

A total of 708 patients (median age 81, 52% male) with severe aortic stenosis (AS) underwent pre-procedural CT and pre- and post-TAVI transthoracic echocardiography. According to the classification of MAC severity determined by CT, 299 (42.2%) patients had no MAC, 229 (32.3%) mild MAC, 102 (14.4%) moderate MAC, and 78 (11.0%) severe MAC. After adjusting for age and sex, there was no significant change in mTMG following TAVI (Delta mTMG = 0.07 mmHg, 95% CI -0.10 to 0.23, P = 0.92) for patients with no MAC. In contrast, patients with mild MAC (Delta mTMG = 0.21 mmHg, 95% CI 0.01 to 0.40, P = 0.018), moderate MAC (Delta mTMG = 0.31 mmHg, 95% CI 0.02 to 0.60, P = 0.019) and severe MAC (Delta mTMG = 0.43 mmHg, 95% CI 0.10 to 0.76, P = 0.0012) had significant increases in mTMG following TAVI, with greater changes associated with increasing MAC severity. In contrast, there was no significant change in MVA or SVi following TAVI.

Conclusion

​​​​​​​In patients with severe AS undergoing TAVI, MAC severity was associated with greater increases in post-procedural mTMG whereas MVA or SVi remained unchanged. MAC severity should be considered for potential subsequent MV interventions if TAVI does not improve symptoms.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 22:45